The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

July 14--A device a fraction of an inch long is providing George Saenz with a peace of mind he has never had before. Three weeks ago, the 67-year-old independent insurance agent had the Medtronic ...

Doctors at Columbus Community Hospital now have a high-tech new tool that can help them diagnose irregular heart rhythms that may not show up during standard testing. The tool, called a cardiac loop ...